SK285338B6 - Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy - Google Patents

Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy Download PDF

Info

Publication number
SK285338B6
SK285338B6 SK293-2001A SK2932001A SK285338B6 SK 285338 B6 SK285338 B6 SK 285338B6 SK 2932001 A SK2932001 A SK 2932001A SK 285338 B6 SK285338 B6 SK 285338B6
Authority
SK
Slovakia
Prior art keywords
ibuprofen
cyclodextrin
pharmaceutical composition
mixing
sodium
Prior art date
Application number
SK293-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK2932001A3 (en
Inventor
P�Rez Mar�A Teresa Tarr�
Casas Montserrat Trullols
Faus Xavier Font
Original Assignee
Laboratorio De Aplicaciones Farmacodinamicas, S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio De Aplicaciones Farmacodinamicas, S. A. filed Critical Laboratorio De Aplicaciones Farmacodinamicas, S. A.
Publication of SK2932001A3 publication Critical patent/SK2932001A3/sk
Publication of SK285338B6 publication Critical patent/SK285338B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SK293-2001A 2000-03-03 2001-03-01 Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy SK285338B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000522A ES2171110B1 (es) 2000-03-03 2000-03-03 Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.

Publications (2)

Publication Number Publication Date
SK2932001A3 SK2932001A3 (en) 2001-12-03
SK285338B6 true SK285338B6 (sk) 2006-11-03

Family

ID=8492565

Family Applications (1)

Application Number Title Priority Date Filing Date
SK293-2001A SK285338B6 (sk) 2000-03-03 2001-03-01 Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy

Country Status (8)

Country Link
EP (1) EP1129709B1 (cs)
AT (1) ATE298567T1 (cs)
CZ (1) CZ301553B6 (cs)
DE (1) DE60111657T2 (cs)
DK (1) DK1129709T3 (cs)
ES (1) ES2171110B1 (cs)
PT (1) PT1129709E (cs)
SK (1) SK285338B6 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
EP1840188B1 (en) 2006-03-31 2011-09-07 Sony Deutschland GmbH A composition comprising at least one type of liquid crystal
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
EP1974751A1 (en) * 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulations for non-steroidal anti-inflammatory drugs
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
CN102448499A (zh) * 2009-04-27 2012-05-09 药效学应用实验室股份有限公司 赖氨酸布洛芬口服混悬剂
EP2253329B1 (en) 2009-04-27 2016-09-21 Laboratorio de Aplicaciones Farmacodinamicas, S.A. Ibuprofen lysinate oral suspension
WO2014194872A1 (en) 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4038314A1 (de) * 1990-11-30 1992-06-04 Puetter Medice Chem Pharm Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
ES2171110B1 (es) 2003-06-16
CZ2001714A3 (cs) 2001-10-17
EP1129709B1 (en) 2005-06-29
SK2932001A3 (en) 2001-12-03
DE60111657T2 (de) 2006-05-04
CZ301553B6 (cs) 2010-04-14
EP1129709A3 (en) 2001-11-14
EP1129709A2 (en) 2001-09-05
DK1129709T3 (da) 2005-10-24
ES2171110A1 (es) 2002-08-16
DE60111657D1 (de) 2005-08-04
PT1129709E (pt) 2005-10-31
ATE298567T1 (de) 2005-07-15

Similar Documents

Publication Publication Date Title
DE69902046T2 (de) Neue feste dosisform enthaltend nanopartikelnaproxen
DE69520768T2 (de) Pharmazeutische Zubereitungen, die Fluoxetin enthalten
US5211958A (en) Pharmaceutical composition and process for its preparation
JP2824678B2 (ja) イブプロフェン風味マスク法
JP3010562B2 (ja) 徐放性調剤単位
DE20218068U1 (de) Arzneimittel
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
BE1000168A3 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol.
JPH10505850A (ja) 単体ガレヌス錠剤の形態の治療用ビタミン−カルシウム複合剤、その製造法および使用法
US5164380A (en) Process for preparing piroxicam/cyclodextrin complexes, the products obtained and their pharmaceutical compositions
SK285338B6 (sk) Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy
JP2008509195A (ja) ドロスピレノンとエチニルエストラジオールを含有する薬学的組成物
DE60203537T2 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
JPH02223526A (ja) 食品用の含水有機溶剤抽出物含有組成物および医薬用の含水有機溶剤抽出物含有組成物、並びにそれらの製造方法
DE10003757A1 (de) Ibuprofen-Wirkstoffzubereitung
JPH0717866A (ja) 医薬組成物
EP2255810A1 (de) Arzneiformen mit kontrollierter Bioverfügbarkeit, die Vardenafil enthalten
DE69709349T2 (de) Arzneimittel bestehend aus diclofenac
DE69328087T2 (de) Verwendung von ibuprofen-beta-cyclodextrin-komplex für die orale verabreichung
DE60306747T2 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
JP2007131561A (ja) 経口固形製剤及びその製造法
JPS62153220A (ja) 胆汁酸内用水剤
DE60103276T2 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
JP2015221806A (ja) ヒトの血小板レベルを増加させるための組成物および方法
DE60120630T2 (de) Pharmazeutische Zusammensetzung enthaltend Xanthangummi

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20160301